We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLBK
2676
DELISTED
Old Line Bancshares, Inc.
OLBK
– –
-1,000
Closed -$29
DF
2677
DELISTED
Dean Foods Company
DF
$0 ﹤0.01%
330
– –
GHDX
2678
DELISTED
Genomic Health, Inc.
GHDX
– –
-1,107
Closed -$74
BPL
2679
DELISTED
Buckeye Partners, L.P.
BPL
– –
-4,375
Closed -$179
LTXB
2680
DELISTED
LegacyTexas Financial Group Inc
LTXB
– –
-352
Closed -$15
CJ
2681
DELISTED
C&J Energy Services, Inc.
CJ
– –
-857
Closed -$9
DEST
2682
DELISTED
Destination Maternity Corporation
DEST
$0 ﹤0.01%
580
– –
MDSO
2683
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-1,769
Closed -$161
RTEC
2684
DELISTED
Rudolph Technologies Inc
RTEC
– –
-592
Closed -$14
ALDR
2685
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-812
Closed -$14
NCI
2686
DELISTED
Navigant Consulting, Inc.
NCI
– –
-588
Closed -$15
TYPE
2687
DELISTED
Monotype Imaging Holdings Inc.
TYPE
– –
-419
Closed -$8
CTWS
2688
DELISTED
Connecticut Water Service Inc
CTWS
– –
-4
Closed –
VSM
2689
DELISTED
Versum Materials, Inc.
VSM
– –
-8,220
Closed -$434
AABA
2690
DELISTED
Altaba Inc
AABA
– –
-3,200
Closed -$61
BID
2691
DELISTED
Sotheby's
BID
– –
-67
Closed -$3
TOWR
2692
DELISTED
Tower International, Inc.
TOWR
– –
-93
Closed -$2
CRAY
2693
DELISTED
Cray, Inc.
CRAY
– –
-54
Closed -$1
BT
2694
DELISTED
BT Group plc (ADR)
BT
$0 ﹤0.01%
4,481
-7,500
-63% –
BRS
2695
DELISTED
Bristow Group, Inc.
BRS
– –
-800
Closed –
NAUH
2696
DELISTED
National American University Holdings, Inc.
NAUH
$0 ﹤0.01%
1,667
– –
EOCC
2697
DELISTED
Enel Generacion Chile S.A.
EOCC
$0 ﹤0.01%
7
– –
WIN
2698
DELISTED
Windstream Holdings Inc
WIN
$0 ﹤0.01%
16
– –
ACTA
2699
DELISTED
Actua Corp
ACTA
$0 ﹤0.01%
168,431
– –
TLOG
2700
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$0 ﹤0.01%
3,925
– –
105 106 107
108
109

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.